Bengt holds a PhD in Immunotechnology from Lund University. He has 20 years of experience heading research groups at Lund University and Denmark Technical University (DTU) within the research areas of immunology, vaccinology, and infectious disease. He has been the main supervisor for several completed PhD and postdoctoral projects. In parallel to his current assignment as the CSO of MinervaX, Bengt is an Associate Professor at the Faculty of Medicine, Lund University.